Answers are grounded in this paper and cite their sources.
Identification of six sesquiterpenoid glycosides shows significant effects on HT-29 cells, suggesting a potential therapy.
Six eudesmane-type sesquiterpenoid glycosides, including one previously undescribed one, pitkercoside A (1), five known analogs, pitsubcosides A, B, K, L (2–5), and pittosporam A (6) were discovered from Pittosporum kerrii Craib. The comprehensive spectroscopic technologies and chemical methods were applied to elucidate the structures of the compounds. Calculated electronic circular dichroism (ECD) technology was applied to determine the absolute configuration of the novel compound (1). Among them, compound 4 (pitsubcoside K, abbreviated as PS-K) exhibited a significant inhibitory effect on HT-29 cellular line with an IC50 value of 4.43 μM. It could up-regulate CHK2 and cause Cdc25A up-regulating, resulting in down-regulating CDK2 expression, which could regulate S-phase progression and cause S-phase arrest. Protein-molecule docking results suggest that PS-K has a strong tendency for spontaneous binding with ATM protein. This study revealed the effective metabolites and molecular mechanisms of P. kerrii, which enlarged the application of the plants of genus Pittosporum.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: